45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
19,023
Insurances with rates
4
CPT / HCPCS codes
15,871
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2351 | Ocrelizumab-Hyaluronidase-ocsq Inj 920-23000 MG-UNIT/23ML | $61,657 | $49,326 | — | — | 10 |
| J9347 | Tremelimumab-actl Soln for IV Infusion 300 MG/15ML | $49,671 | $39,737 | — | — | 10 |
| J2350 | Ocrelizumab Soln For IV Infusion 300 MG/10ML | $38,913 | $31,130 | — | — | 10 |
| J3357 | Ustekinumab Soln Prefilled Syringe 90 MG/ML | $38,816 | $31,052 | — | — | 10 |
| 77372 | SRS - 1 SESSION | $32,540 | $26,032 | — | — | 10 |
| J9298 | Nivolumab-Relatlimab-rmbw 240-80 MG/20ML | $29,570 | $23,656 | — | — | 10 |
| G0339 | STEREOTACTIC RAD TRTMT | $23,243 | $18,594 | — | — | 7 |
| J0870 | Imetelstat Sodium For IV Soln 188 MG | $20,332 | $16,266 | — | — | 10 |
| J2327 | Risankizumab-rzaa IV Soln 600 MG/10ML (60 MG/ML) | $20,216 | $16,173 | — | — | 10 |
| J9144 | Daratumumab-Hyaluronidase-fihj Inj 1800-30000 MG-Unit/15ML | $19,388 | $15,510 | — | — | 10 |
| J1930 | Lanreotide Acetate Extended Release Inj 120 MG/0.5ML | $19,199 | $15,359 | — | — | 10 |
| J9228 | Ipilimumab Soln for IV Infusion 50 MG/10ML (5 MG/ML) | $17,518 | $14,014 | — | — | 10 |
| J3380 | Vedolizumab For IV Solution 300 MG | $17,319 | $13,855 | — | — | 10 |
| J9301 | Obinutuzumab Soln for IV Infusion 1000 MG/40ML (25 MG/ML) | $16,599 | $13,279 | — | — | 10 |
| J9022 | Atezolizumab IV Soln 1200 MG/20ML | $16,508 | $13,206 | — | — | 10 |
| J9223 | Lurbinectedin For IV Soln 4 MG | $16,178 | $12,942 | — | — | 10 |
| J9119 | Cemiplimab-rwlc IV Soln 350 MG/7ML (50 MG/ML) | $15,568 | $12,454 | — | — | 10 |
| J9311 | Rituximab-Hyaluronidase Human Inj 1600-26800 MG-Unit/13.4ML | $15,150 | $12,120 | — | — | 10 |
| J9380 | Teclistamab-cqyv Subcutaneous Soln 153 MG/1.7ML (90 MG/ML) | $14,548 | $11,638 | — | — | 10 |
| 77373 | SRT SBRT - 5 SESSION MAX | $14,181 | $11,345 | — | — | 10 |
| J9306 | Pertuzumab Soln for IV Infusion 420 MG/14ML (30 MG/ML) | $13,186 | $10,549 | — | — | 10 |
| J3101 | Tenecteplase For IV Soln Kit 50 MG | $12,147 | $9,718 | — | — | 30 |
| J9271 | Pembrolizumab IV Soln 100 MG/4ML (25 MG/ML) | $11,480 | $9,184 | — | — | 20 |
| 77301 | RADIATION THER TRMT PLAN | $11,036 | $8,829 | — | — | 10 |
| G0340 | STEROTATC RAD TRTMT SESS | $10,938 | $8,750 | — | — | 7 |
| J0517 | Benralizumab Subcutaneous Soln Prefilled Syringe 30 MG/ML | $10,072 | $8,057 | — | — | 10 |
| J9356 | Trastuzumab-Hyaluronidase-oysk Inj 600-10000 MG-Unit/5ML | $9,550 | $7,640 | — | — | 10 |
| 77295 | 3-D SIM THERAPY RAD | $9,284 | $7,427 | — | — | 10 |
| J2506 | Pegfilgrastim Soln Prefilled Syringe Kit 6 MG/0.6ML | $9,113 | $7,291 | — | — | 10 |
| J1162 | Digoxin Immune Fab For Inj 40 MG | $8,948 | $7,159 | — | — | 10 |
| J9295 | Necitumumab IV Soln 800 MG/50ML (16 MG/ML) | $8,819 | $7,055 | — | — | 10 |
| J9177 | Enfortumab Vedotin-ejfv For IV Soln 30 MG | $8,627 | $6,902 | — | — | 10 |
| J9358 | Fam-Trastuzumab Deruxtecan-nxki For IV Soln 100 MG | $8,582 | $6,866 | — | — | 10 |
| J2353 | Octreotide Acetate For IM Inj Kit 20 MG | $8,554 | $6,843 | — | — | 10 |
| J9173 | Durvalumab Soln for IV Infusion 500 MG/10ML (50 MG/ML) | $8,414 | $6,731 | — | — | 10 |
| 78816 | PET CT WHOLE BODY | $8,333 | $6,666 | — | — | 10 |
| Q5127 | Pegfilgrastim-fpgk Soln Prefilled Syringe 6 MG/0.6ML | $8,270 | $6,616 | — | — | 10 |
| 78815 | PET CT SKULL BASE TO MID THIGH | $8,153 | $6,523 | — | — | 10 |
| J9354 | Ado-Trastuzumab Emtansine For IV Soln 100 MG | $8,021 | $6,417 | — | — | 10 |
| J0896 | Luspatercept-aamt For Subcutaneous Inj 25 MG | $7,942 | $6,353 | — | — | 10 |
| 77307 | TELETHERAPY ISODOSE PLAN COMPLEX INCLUD BASIC DOSIM CAL | $7,719 | $6,175 | — | — | 10 |
| 49418 | SURG 49418 PLCMNT PERITONEAL CATH TUN W/IMG GUID | $7,683 | $6,146 | — | — | 10 |
| J0565 | Bezlotoxumab IV Soln 1000 MG/40ML (25 MG/ML) | $7,636 | $6,109 | — | — | 20 |
| J9317 | Sacituzumab Govitecan-hziy For IV Soln 180 MG | $7,555 | $6,044 | — | — | 10 |
| J9043 | Cabazitaxel Inj 60 MG/1.5ML (For IV Infusion) | $7,447 | $5,958 | — | — | 10 |
| Q5116 | Trastuzumab-qyyp For IV Soln 420 MG | $7,446 | $5,957 | — | — | 20 |
| 78608 | PET BRAIN METABOLIC EVAL | $7,441 | $5,953 | — | — | 10 |
| J2182 | Mepolizumab Subcutaneous Solution Auto-injector 100 MG/ML | $7,415 | $5,932 | — | — | 10 |
| Q5117 | Trastuzumab-anns For IV Soln 420 MG | $7,385 | $5,908 | — | — | 10 |
| 78814 | PET CT LIMITED AREA | $6,962 | $5,570 | — | — | 10 |
Showing top 50 of 19,023 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.